The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
KEYTRUDA is the first and only immunotherapy-based regimen to show a statistically significant and clinically meaningful improvement in overall survival
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The acquisition is based on an enterprise value of Rs. 1,660 crore
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
Subscribe To Our Newsletter & Stay Updated
